scispace - formally typeset
J

John Kuriyan

Researcher at University of California, Berkeley

Publications -  282
Citations -  49707

John Kuriyan is an academic researcher from University of California, Berkeley. The author has contributed to research in topics: DNA polymerase & Proto-oncogene tyrosine-protein kinase Src. The author has an hindex of 103, co-authored 274 publications receiving 46431 citations. Previous affiliations of John Kuriyan include Memorial Sloan Kettering Cancer Center & California Institute for Quantitative Biosciences.

Papers
More filters
Journal ArticleDOI

Crystallographic R Factor Refinement by Molecular Dynamics

TL;DR: Test cases showed that the need for manual corrections during refinement of macromolecular crystal structures is reduced and the dynamics calculation moved residues that were misplaced by more than 3 angstroms into the correct positions without human intervention.
Journal ArticleDOI

Structural mechanism for STI-571 inhibition of abelson tyrosine kinase

TL;DR: The results suggest that compounds that exploit the distinctive inactivation mechanisms of individual protein kinases can achieve both high affinity and high specificity.
Journal ArticleDOI

Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia

TL;DR: Through sequencing analysis of blood or bone marrow samples from patients with chronic myeloid leukemia, BCR-ABL kinase domain mutations in 29 of 32 patients whose disease relapsed after an initial response to the tyrosine kinase inhibitor imatinib are identified.
Journal ArticleDOI

The Conformational Plasticity of Protein Kinases

TL;DR: Crystal structures of inactive kinases have revealed a remarkable plasticity in the kinase domain that allows the adoption of distinct conformations in response to interactions with specific regulatory domains or proteins.

Structural Mechanism for STI-571 Inhibition of Abelson

TL;DR: The crystal structure of the catalytic domain of the Abelson tyrosine kinase (Abl) complexed to a variant of STI-571 is reported in this paper.